title: Susac's syndrome: improvement with combined antiplatelet and calcium antagonist therapy.
authors.forename: B
authors.initials: B
authors.lastname: Wildemann
authors.forename: C
authors.initials: C
authors.lastname: Schülin
authors.forename: B
authors.initials: B
authors.lastname: Storch-Hagenlocher
authors.forename: W
authors.initials: W
authors.lastname: Hacke
authors.forename: S
authors.initials: S
authors.lastname: Dithmar
authors.forename: K
authors.initials: K
authors.lastname: Kirchhof
authors.forename: O
authors.initials: O
authors.lastname: Jansen
authors.forename: A
authors.initials: A
authors.lastname: Breitbart
mesh_terms: D000328:Adult; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D004338:Drug Combinations; D005260:Female; D006312:Hearing Loss, Bilateral / Q000188:drug therapy*; D006319:Hearing Loss, Sensorineural / Q000188:drug therapy*; D006801:Humans; D007238:Infarction / Q000188:drug therapy; D009553:Nimodipine / Q000008:administration & dosage / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D015356:Retinal Artery Occlusion / Q000188:drug therapy*; D013577:Syndrome; D014786:Vision Disorders / Q000188:drug therapy
chemical_list: D002121:Calcium Channel Blockers; D004338:Drug Combinations; D010975:Platelet Aggregation Inhibitors; D009553:Nimodipine; D001241:Aspirin